Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What more can we ask from the pathologist?

V J Desmet1

  • 1K. U. Leuven, Laboratory of Histochemistry and Cytochemistry, Belgium.

Journal of Hepatology
|January 1, 1996
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comments on cirrhosis reversal.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2005
Same author

Histopathology of chronic cholestasis and adult ductopenic syndrome.

Clinics in liver disease·2004
Same author

Reversal of cirrhosis: evidence-based medicine?

Gastroenterology·2003
Same author

Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors.

Hepatology (Baltimore, Md.)·2000
Same author

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Journal of hepatology·1999
Same author

Expression of cytokeratin 20 in developing rat liver and in experimental models of ductular and oval cell proliferation.

Journal of hepatology·1998
Same journal

Optimising the screening strategy for early-stage hepatocellular carcinoma.

Journal of hepatology·2026
Same journal

Corrigendum to: "A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse" [J Hepatol (2014) 60: 782-91].

Journal of hepatology·2026
Same journal

Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort.

Journal of hepatology·2026
Same journal

Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial.

Journal of hepatology·2026
Same journal

Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study.

Journal of hepatology·2026
Same journal

Reply to "Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy".

Journal of hepatology·2026
See all related articles